The Cooper Companies, Inc. (COO)
NASDAQ: COO · Real-Time Price · USD
73.26
-0.18 (-0.25%)
At close: Aug 15, 2025, 4:00 PM
74.02
+0.76 (1.04%)
After-hours: Aug 15, 2025, 6:39 PM EDT
Revenue by Product
Fiscal year is November - October.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2013 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 | Oct '20 Oct 31, 2020 | 2013 - 2019 |
| Toric Lens | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Toric Lens Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Multifocal Lens | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Multifocal Lens Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Single-Use Sphere Lens | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Single-Use Sphere Lens Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Non Single-Use Sphere Lens and Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Non Single-Use Sphere Lens and Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Total CooperVision | 2.61B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Total CooperVision Growth | 6.26% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Office and Surgical Products | 774.70M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Office and Surgical Products Growth | 9.53% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Fertility | 511.30M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Fertility Growth | 6.05% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Toric and Multifocal | 1.26B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Sphere, Other | 1.35B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
EBIT by Product
Fiscal year is November - October.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2013 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 | Oct '20 Oct 31, 2020 | 2013 - 2019 |
| Other | 2.20M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| CooperVision Operating Income | 676.20M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| CooperVision Operating Income Growth | 20.97% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| CooperSurgical Operating Income | 118.30M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| CooperSurgical Operating Income Growth | 45.39% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Corporate Operating Income | -88.80M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Corporate Operating Income Growth | 9.18% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 2.20M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is November - October.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2013 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 | Oct '20 Oct 31, 2020 | 2013 - 2019 |
| United States | 1.97B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States Growth | 7.67% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe | 1.16B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe Growth | 7.77% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rest Of The World | 773.60M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rest Of The World Growth | 3.61% |
Log In |
Log In |
Log In |
Log In | Upgrade
|